 | JEQ | Name: | 5-azanyl-3-[1-[[(3~{R})-1-(phenylmethyl)piperidin-3-yl]methyl]indol-6-yl]-1~{H}-pyrazole-4-carbonitrile | Formula: | C25 H26 N6 | SMILES: | Nc1[nH]nc(c2ccc3ccn(C[CH]4CCCN(C4)Cc5ccccc5)c3c2)c1C#N | InChi: | InChI=1S/C25H26N6/c26-14-22-24(28-29-25(22)27)21-9-8-20-10-12-31(23(20)13-21)17-19-7-4-11-30(16-19)15-18-5-2-1-3-6-18/h1-3,5-6,8-10,12-13,19H,4,7,11,15-17H2,(H3,27,28,29)/t19-/m1/s1 | Definition date: | 2019-02-19 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 5-azanyl-3-[1-[[(3~{R})-1-(phenylmethyl)piperidin-3-yl]methyl]indol-6-yl]-1~{H}-pyrazole-4-carbonitrile |
|
 | JFH | Name: | 3-[1-[[4-(pyrrolidin-1-ylmethyl)phenyl]methyl]indol-6-yl]-1~{H}-pyrazol-5-amine | Formula: | C23 H25 N5 | SMILES: | Nc1[nH]nc(c1)c2ccc3ccn(Cc4ccc(CN5CCCC5)cc4)c3c2 | InChi: | InChI=1S/C23H25N5/c24-23-14-21(25-26-23)20-8-7-19-9-12-28(22(19)13-20)16-18-5-3-17(4-6-18)15-27-10-1-2-11-27/h3-9,12-14H,1-2,10-11,15-16H2,(H3,24,25,26) | Definition date: | 2019-02-19 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 3-[1-[[4-(pyrrolidin-1-ylmethyl)phenyl]methyl]indol-6-yl]-1~{H}-pyrazol-5-amine |
|
 | JGH | Name: | 1:2 Ce-substituted Keggin | Formula: | Ce H2 O78 P2 W22 | SMILES: | O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O1[PH]23[O]45[W]678O[W]9%10O[W]1%11%12O[W]4%13(O6)O[W]%14%15(O%11)O[W]%16%17%18O[W]5(O7)(O%13)O[W]%19%20(O[W]%21(O9)(O8)O[W]%22(O%19)(O[W](O%14)(O%16)(O[Ce]%23%24%25(O%10)(O[W]%26%27O[W]%28%29(O[PH]%30%31[O]%32%33[W]%34%35(O%26)O[W]%36%37(O%27)O[W]%38%39%40O[W]%32%41(O%34)O[W]%33(O%28)(O%35)O[W]%42%43(O%29)O[W]%44(O%41)(O%38)O[W](O%42)(O[W](O%36)(O%39)(O%23)[O]%30%37%40)(O%24)[O]%31%43%44)O%25)(O%12)O%22)[O]2%15%17)[O]3%20%21)O%18 | InChi: | InChI=1S/Ce.2HO4P.22H2O.48O.22W/c | Definition date: | 2019-02-21 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 |
|
 | JGK | Name: | ~{N}-[3-(3-azanyl-5-methyl-1,2-oxazol-4-yl)-5-(5-ethanoyl-2-ethoxy-phenyl)phenyl]furan-2-carboxamide | Formula: | C25 H23 N3 O5 | SMILES: | CCOc1ccc(cc1c2cc(NC(=O)c3occc3)cc(c2)c4c(C)onc4N)C(C)=O | InChi: | InChI=1S/C25H23N3O5/c1-4-31-21-8-7-16(14(2)29)13-20(21)17-10-18(23-15(3)33-28-24(23)26)12-19(11-17)27-25(30)22-6-5-9-32-22/h5-13H,4H2,1-3H3,(H2,26,28)(H,27,30) | Definition date: | 2019-02-22 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | ~{N}-[3-(3-azanyl-5-methyl-1,2-oxazol-4-yl)-5-(5-ethanoyl-2-ethoxy-phenyl)phenyl]furan-2-carboxamide |
|
 | JH8 | Name: | 2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-~{N},~{N}-dimethyl-ethanamide | Formula: | C22 H20 N4 O | SMILES: | CN(C)C(=O)Cn1cc(cn1)c2ccc(cc2)c3cncc4ccccc34 | InChi: | InChI=1S/C22H20N4O/c1-25(2)22(27)15-26-14-19(12-24-26)16-7-9-17(10-8-16)21-13-23-11-18-5-3-4-6-20(18)21/h3-14H,15H2,1-2H3 | Definition date: | 2019-02-25 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-~{N},~{N}-dimethyl-ethanamide |
|
 | M36 | Name: | 7-[8-methoxy-2,2-dimethyl-7-(3-methylbut-2-enyl)-5-oxidanyl-6-oxidanylidene-pyrano[3,2-b]xanthen-9-yl]oxyheptanoic acid | Formula: | C31 H36 O8 | SMILES: | COc1c(CC=C(C)C)c2C(=O)c3c(O)c4C=CC(C)(C)Oc4cc3Oc2cc1OCCCCCCC(O)=O | InChi: | InChI=1S/C31H36O8/c1-18(2)11-12-20-26-22(17-24(30(20)36-5)37-15-9-7-6-8-10-25(32)33)38-23-16-21-19(13-14-31(3,4)39-21)28(34)27(23)29(26)35/h11,13-14,16-17,34H,6-10,12,15H2,1-5H3,(H,32,33) | Definition date: | 2019-07-26 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 7-[8-methoxy-2,2-dimethyl-7-(3-methylbut-2-enyl)-5-oxidanyl-6-oxidanylidene-pyrano[3,2-b]xanthen-9-yl]oxyheptanoic acid |
|
 | M6O | Name: | lauric acid functionalized hexamolybdoaluminate | Formula: | C16 H30 Al Mo6 N O25 | SMILES: | O.O.O.O.O.O.O.O.O.O.O.O.CCCCCCCCCCCC(=O)N[C]12C[O]34[Mo]5O[Mo]36O[Mo]7O[Mo]89O[Mo]%10(O8)O[Mo]%11(O5)O[Al]4(O6)([O]79C1)[O]%10%11C2 | InChi: | InChI=1S/C16H30NO4.Al.6Mo.12H2O.9O/c1-2-3-4-5-6-7-8-9-10-11-15(21)17-16(12-18,13-19)14-20 | Definition date: | 2020-01-23 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 |
|
 | VMC | Name: | 2-methoxy-4-(1-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-4-phenyl-1H-imidazol-5-yl)phenol | Formula: | C23 H27 N3 O2 | SMILES: | Oc1c(OC)cc(cc1)c2n(cnc2c3ccccc3)CCC4N(CCC4)C | InChi: | InChI=1S/C23H27N3O2/c1-25-13-6-9-19(25)12-14-26-16-24-22(17-7-4-3-5-8-17)23(26)18-10-11-20(27)21(15-18)28-2/h3-5,7-8,10-11,15-16,19,27H,6,9,12-14H2,1-2H3/t19-/m0/s1 | Definition date: | 2019-09-06 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 2-methoxy-4-(1-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-4-phenyl-1H-imidazol-5-yl)phenol |
|
 | BVO | Name: | 3-[3,5-bis(fluoranyl)-4-[3-(hydroxymethyl)phenyl]phenyl]benzo[f]benzotriazole-4,9-dione | Formula: | C23 H13 F2 N3 O3 | SMILES: | OCc1cccc(c1)c2c(F)cc(cc2F)n3nnc4C(=O)c5ccccc5C(=O)c34 | InChi: | InChI=1S/C23H13F2N3O3/c24-17-9-14(10-18(25)19(17)13-5-3-4-12(8-13)11-29)28-21-20(26-27-28)22(30)15-6-1-2-7-16(15)23(21)31/h1-10,29H,11H2 | Definition date: | 2019-03-14 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 3-[3,5-bis(fluoranyl)-4-[3-(hydroxymethyl)phenyl]phenyl]benzo[f]benzotriazole-4,9-dione |
|
 | BVU | Name: | 3-[3,5-bis(fluoranyl)-4-(2-fluorophenyl)phenyl]benzo[f]benzotriazole-4,9-dione | Formula: | C22 H10 F3 N3 O2 | SMILES: | Fc1ccccc1c2c(F)cc(cc2F)n3nnc4C(=O)c5ccccc5C(=O)c34 | InChi: | InChI=1S/C22H10F3N3O2/c23-15-8-4-3-7-14(15)18-16(24)9-11(10-17(18)25)28-20-19(26-27-28)21(29)12-5-1-2-6-13(12)22(20)30/h1-10H | Definition date: | 2019-03-14 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | 3-[3,5-bis(fluoranyl)-4-(2-fluorophenyl)phenyl]benzo[f]benzotriazole-4,9-dione |
|
 | BW9 | Name: | Chromium Protoporphyrin IX | Formula: | C34 H32 Cr N4 O4 | SMILES: | CC1=C(CCC(O)=O)C2=NC1=Cc3n4[Cr][N]5C(=CC6=NC(=Cc4c(C=C)c3C)C(=C6C=C)C)C(=C(CCC(O)=O)C5=C2)C | InChi: | InChI=1S/C34H34N4O4.Cr/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25 | Definition date: | 2019-03-19 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 |
|
 | CO0 | Name: | (3~{Z})-4-methyl-3-(phenylmethylidene)-1~{H}-1,4-benzodiazepine-2,5-dione | Formula: | C17 H14 N2 O2 | SMILES: | CN1C(=O)c2ccccc2NC(=O)C1=Cc3ccccc3 | InChi: | InChI=1S/C17H14N2O2/c1-19-15(11-12-7-3-2-4-8-12)16(20)18-14-10-6-5-9-13(14)17(19)21/h2-11H,1H3,(H,18,20)/b15-11- | Definition date: | 2019-05-10 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | (3~{Z})-4-methyl-3-(phenylmethylidene)-1~{H}-1,4-benzodiazepine-2,5-dione |
|
 | CQ9 | Name: | (3~{R},3'~{S})-4-methyl-3'-phenyl-spiro[1~{H}-1,4-benzodiazepine-3,2'-oxirane]-2,5-dione | Formula: | C17 H14 N2 O3 | SMILES: | CN1C(=O)c2ccccc2NC(=O)[C]13O[CH]3c4ccccc4 | InChi: | InChI=1S/C17H14N2O3/c1-19-15(20)12-9-5-6-10-13(12)18-16(21)17(19)14(22-17)11-7-3-2-4-8-11/h2-10,14H,1H3,(H,18,21)/t14-,17+/m0/s1 | Definition date: | 2019-05-10 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | (3~{R},3'~{S})-4-methyl-3'-phenyl-spiro[1~{H}-1,4-benzodiazepine-3,2'-oxirane]-2,5-dione |
|
 | MI9 | Name: | Oxomolybdenum Mesoporphyrin IX | Formula: | C34 H36 Mo N4 O5 | SMILES: | CCC1=C(C)C2=NC1=Cc3n4c(C=C5N=C(C=C6[N](C(=C2)C(=C6CCC(O)=O)C)[Mo]4=O)C(=C5C)CCC(O)=O)c(CC)c3C | InChi: | InChI=1S/C34H38N4O4.Mo.O/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25 | Definition date: | 2019-03-12 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 |
|
 | CV0 | Name: | MESOPORPHYRIN IX CONTAINING Rh | Formula: | C34 H36 N4 O4 Rh | SMILES: | CCC1=C(C)C2=Cc3n4[Rh][N]5C(=CC1=N2)C(=C(CCC(O)=O)C5=CC6=NC(=Cc4c(C)c3CC)C(=C6CCC(O)=O)C)C | InChi: | InChI=1S/C34H38N4O4.Rh/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25 | Definition date: | 2019-05-17 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 |
|
 | CV3 | Name: | (3~{Z})-4-methyl-3-[[4-(trifluoromethyl)phenyl]methylidene]-1~{H}-1,4-benzodiazepine-2,5-dione | Formula: | C18 H13 F3 N2 O2 | SMILES: | CN1C(=O)c2ccccc2NC(=O)C1=Cc3ccc(cc3)C(F)(F)F | InChi: | InChI=1S/C18H13F3N2O2/c1-23-15(10-11-6-8-12(9-7-11)18(19,20)21)16(24)22-14-5-3-2-4-13(14)17(23)25/h2-10H,1H3,(H,22,24)/b15-10- | Definition date: | 2019-05-20 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | (3~{Z})-4-methyl-3-[[4-(trifluoromethyl)phenyl]methylidene]-1~{H}-1,4-benzodiazepine-2,5-dione |
|
 | MNZ | Name: | (4~{a}~{R},5~{S},6~{R},8~{S},8~{a}~{R})-5-[2-(furan-3-yl)ethyl]-5,6,8~{a}-trimethyl-8-oxidanyl-3,4,4~{a},6,7,8-hexahydronaphthalene-1-carboxylic acid | Formula: | C20 H28 O4 | SMILES: | C[CH]1C[CH](O)[C]2(C)[CH](CCC=C2C(O)=O)[C]1(C)CCc3cocc3 | InChi: | InChI=1S/C20H28O4/c1-13-11-17(21)20(3)15(18(22)23)5-4-6-16(20)19(13,2)9-7-14-8-10-24-12-14/h5,8,10,12-13,16-17,21H,4,6-7,9,11H2,1-3H3,(H,22,23)/t13-,16-,17+,19+,20+/m1/s1 | Definition date: | 2019-10-18 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | (4~{a}~{R},5~{S},6~{R},8~{S},8~{a}~{R})-5-[2-(furan-3-yl)ethyl]-5,6,8~{a}-trimethyl-8-oxidanyl-3,4,4~{a},6,7,8-hexahydronaphthalene-1-carboxylic acid |
|
 | D0L | Name: | (2S)-2-[[(2S)-1-heptylpyrrolidin-2-yl]carbonylamino]-3-phenyl-propanoic acid | Formula: | C21 H32 N2 O3 | SMILES: | CCCCCCCN1CCC[CH]1C(=O)N[CH](Cc2ccccc2)C(O)=O | InChi: | InChI=1S/C21H32N2O3/c1-2-3-4-5-9-14-23-15-10-13-19(23)20(24)22-18(21(25)26)16-17-11-7-6-8-12-17/h6-8,11-12,18-19H,2-5,9-10,13-16H2,1H3,(H,22,24)(H,25,26)/t18-,19-/m0/s1 | Definition date: | 2019-05-29 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | (2~{S})-2-[[(2~{S})-1-heptylpyrrolidin-2-yl]carbonylamino]-3-phenyl-propanoic acid |
|
 | T2C | Name: | (2S)-1,3-thiazolidine-2-carboxylic acid | Formula: | C4 H7 N O2 S | SMILES: | C1(C(O)=O)NCCS1 | InChi: | InChI=1S/C4H7NO2S/c6-4(7)3-5-1-2-8-3/h3,5H,1-2H2,(H,6,7)/t3-/m0/s1 | Definition date: | 2019-09-25 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | (2S)-1,3-thiazolidine-2-carboxylic acid |
|
 | EAR | Name: | ethyl 2-[2-(4-chlorophenyl)-7-methyl-5-oxidanylidene-imidazo[1,2-a]pyrimidin-8-yl]ethanoate | Formula: | C17 H16 Cl N3 O3 | SMILES: | CCOC(=O)CN1C(=CC(=O)n2cc(nc12)c3ccc(Cl)cc3)C | InChi: | InChI=1S/C17H16ClN3O3/c1-3-24-16(23)10-20-11(2)8-15(22)21-9-14(19-17(20)21)12-4-6-13(18)7-5-12/h4-9H,3,10H2,1-2H3 | Definition date: | 2019-12-04 | Last modified: | 2020-03-13 | Release date: | 2020-03-18 | Identifier: | ethyl 2-[2-(4-chlorophenyl)-7-methyl-5-oxidanylidene-imidazo[1,2-a]pyrimidin-8-yl]ethanoate |
|
 | DML | Name: | TERMINAL DIMETHYL | Formula: | C2 H6 | SMILES: | [CH3].[CH3] | InChi: | InChI=1/2CH4/h2*1H4 | Definition date: | 1999-07-08 | Last modified: | 2020-03-11 | Identifier: | $l^{3}-carbane |
|
 | O5D | Name: | [3-(5-amino-4-methylpyridin-2-yl)-1H-pyrazol-5-yl]{(3R)-3-[(2-chloro-6-methoxyphenyl)methyl]morpholin-4-yl}methanone | Formula: | C22 H24 Cl N5 O3 | SMILES: | c1(nnc(c1)c2cc(c(cn2)N)C)C(N4CCOCC4Cc3c(cccc3OC)Cl)=O | InChi: | InChI=1S/C22H24ClN5O3/c1-13-8-18(25-11-17(13)24)19-10-20(27-26-19)22(29)28-6-7-31-12-14(28)9-15-16(23)4-3-5-21(15)30-2/h3-5,8,10-11,14H,6-7,9,12,24H2,1-2H3,(H,26,27)/t14-/m1/s1 | Definition date: | 2019-06-11 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | [3-(5-amino-4-methylpyridin-2-yl)-1H-pyrazol-5-yl]{(3R)-3-[(2-chloro-6-methoxyphenyl)methyl]morpholin-4-yl}methanone |
|
 | O5G | Name: | {(3R)-3-[(2-methoxyphenyl)methyl]morpholin-4-yl}[3-(4-methylpyridin-2-yl)-1H-pyrazol-5-yl]methanone | Formula: | C22 H24 N4 O3 | SMILES: | c3(C(N2CCOCC2Cc1ccccc1OC)=O)cc(nn3)c4cc(ccn4)C | InChi: | InChI=1S/C22H24N4O3/c1-15-7-8-23-18(11-15)19-13-20(25-24-19)22(27)26-9-10-29-14-17(26)12-16-5-3-4-6-21(16)28-2/h3-8,11,13,17H,9-10,12,14H2,1-2H3,(H,24,25)/t17-/m1/s1 | Definition date: | 2019-06-11 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | {(3R)-3-[(2-methoxyphenyl)methyl]morpholin-4-yl}[3-(4-methylpyridin-2-yl)-1H-pyrazol-5-yl]methanone |
|
 | O5M | Name: | {(3R)-3-[(2-fluorophenyl)methyl]morpholin-4-yl}[3-(4-methylpyridin-2-yl)-1H-pyrazol-5-yl]methanone | Formula: | C21 H21 F N4 O2 | SMILES: | c3(C(N2CCOCC2Cc1c(cccc1)F)=O)cc(nn3)c4cc(ccn4)C | InChi: | InChI=1S/C21H21FN4O2/c1-14-6-7-23-18(10-14)19-12-20(25-24-19)21(27)26-8-9-28-13-16(26)11-15-4-2-3-5-17(15)22/h2-7,10,12,16H,8-9,11,13H2,1H3,(H,24,25)/t16-/m1/s1 | Definition date: | 2019-06-11 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | {(3R)-3-[(2-fluorophenyl)methyl]morpholin-4-yl}[3-(4-methylpyridin-2-yl)-1H-pyrazol-5-yl]methanone |
|
 | O5P | Name: | [(3R)-3-benzylmorpholin-4-yl][5-(4-methylpyridin-2-yl)-1H-pyrazol-3-yl]methanone | Formula: | C21 H22 N4 O2 | SMILES: | c4(cc(c3cc(C(N2CCOCC2Cc1ccccc1)=O)nn3)ncc4)C | InChi: | InChI=1S/C21H22N4O2/c1-15-7-8-22-18(11-15)19-13-20(24-23-19)21(26)25-9-10-27-14-17(25)12-16-5-3-2-4-6-16/h2-8,11,13,17H,9-10,12,14H2,1H3,(H,23,24)/t17-/m1/s1 | Definition date: | 2019-06-11 | Last modified: | 2020-03-06 | Release date: | 2020-03-11 | Identifier: | [(3R)-3-benzylmorpholin-4-yl][5-(4-methylpyridin-2-yl)-1H-pyrazol-3-yl]methanone |
|